{"id":"https://openalex.org/W4386282191","doi":"https://doi.org/10.1016/s2152-2650(23)01195-3","title":"MDS-539 Understanding the Real-World Clinical Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)","display_name":"MDS-539 Understanding the Real-World Clinical Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)","publication_year":2023,"publication_date":"2023-08-30","ids":{"openalex":"https://openalex.org/W4386282191","doi":"https://doi.org/10.1016/s2152-2650(23)01195-3"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(23)01195-3","doi":"https://doi.org/10.1016/s2152-2650(23)01195-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(23)01195-3","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018935336","display_name":"Jesse Fishman","orcid":"https://orcid.org/0009-0002-8729-7435","observed_orcids":["https://orcid.org/0009-0002-8729-7435"]},"institutions":[{"id":"https://openalex.org/I4210120540","display_name":"Apellis Pharmaceuticals (United States)","ror":"https://ror.org/0231n7e68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210120540"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jesse Fishman","raw_affiliation_strings":["Apellis Pharmaceuticals, Inc., Waltham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Apellis Pharmaceuticals, Inc., Waltham, USA","institution_ids":["https://openalex.org/I4210120540"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013094337","display_name":"Carly S Rich","orcid":"https://orcid.org/0000-0003-4717-5855","observed_orcids":["https://orcid.org/0000-0003-4717-5855"]},"institutions":[{"id":"https://openalex.org/I4210137624","display_name":"Swedish Orphan Biovitrum (Sweden)","ror":"https://ror.org/04asvbz37","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210137624"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Carly Rich","raw_affiliation_strings":["Swedish Orphan Biovitrum AB, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Swedish Orphan Biovitrum AB, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210137624"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109810802","display_name":"Koo Wilson","orcid":"https://orcid.org/0000-0002-8732-8249","observed_orcids":["https://orcid.org/0000-0002-8732-8249"]},"institutions":[{"id":"https://openalex.org/I4210137624","display_name":"Swedish Orphan Biovitrum (Sweden)","ror":"https://ror.org/04asvbz37","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210137624"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Koo Wilson","raw_affiliation_strings":["Swedish Orphan Biovitrum AB, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Swedish Orphan Biovitrum AB, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210137624"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092817184","display_name":"Jennifer Mellor-Bowman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091464","display_name":"Adelphi Group (United Kingdom)","ror":"https://ror.org/00egpfv87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091464"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jennifer Mellor-Bowman","raw_affiliation_strings":["Adelphi Real World, Bollington, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Real World, Bollington, United Kingdom","institution_ids":["https://openalex.org/I4210091464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113112394","display_name":"Lucy Earl","orcid":"https://orcid.org/0009-0004-1770-0772","observed_orcids":["https://orcid.org/0009-0004-1770-0772"]},"institutions":[{"id":"https://openalex.org/I4210091464","display_name":"Adelphi Group (United Kingdom)","ror":"https://ror.org/00egpfv87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091464"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lucy Earl","raw_affiliation_strings":["Adelphi Real World, Bollington, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Real World, Bollington, United Kingdom","institution_ids":["https://openalex.org/I4210091464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104277938","display_name":"Yasmin Taylor","orcid":"https://orcid.org/0000-0003-4454-5013","observed_orcids":["https://orcid.org/0000-0003-4454-5013"]},"institutions":[{"id":"https://openalex.org/I4210091464","display_name":"Adelphi Group (United Kingdom)","ror":"https://ror.org/00egpfv87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091464"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Yasmin Taylor","raw_affiliation_strings":["Adelphi Real World, Bollington, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Real World, Bollington, United Kingdom","institution_ids":["https://openalex.org/I4210091464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105167226","display_name":"Alice Simons","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091464","display_name":"Adelphi Group (United Kingdom)","ror":"https://ror.org/00egpfv87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091464"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alice Simons","raw_affiliation_strings":["Adelphi Real World, Bollington, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Real World, Bollington, United Kingdom","institution_ids":["https://openalex.org/I4210091464"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5114162510","display_name":"Joe Conyers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091464","display_name":"Adelphi Group (United Kingdom)","ror":"https://ror.org/00egpfv87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091464"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joe Conyers","raw_affiliation_strings":["Adelphi Real World, Bollington, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Real World, Bollington, United Kingdom","institution_ids":["https://openalex.org/I4210091464"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3670,"currency":"USD","value_usd":3670},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":null,"first_page":"S369","last_page":"S370"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paroxysmal-nocturnal-hemoglobinuria","display_name":"paroxysmal nocturnal hemoglobinuria","score":1.0},{"id":"https://openalex.org/keywords/complement-inhibition","display_name":"complement inhibition","score":0.6000000238418579},{"id":"https://openalex.org/keywords/hemolysis","display_name":"hemolysis","score":0.7179999947547913},{"id":"https://openalex.org/keywords/hemoglobin","display_name":"hemoglobin","score":0.6480000019073486},{"id":"https://openalex.org/keywords/lactate-dehydrogenase","display_name":"lactate dehydrogenase","score":0.9890000224113464},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.9210000038146973},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.8859999775886536},{"id":"https://openalex.org/keywords/treatment-satisfaction","display_name":"treatment satisfaction","score":0.9819999933242798},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.8339999914169312},{"id":"https://openalex.org/keywords/physician-reported-outcomes","display_name":"physician-reported outcomes","score":0.578000009059906},{"id":"https://openalex.org/keywords/disease-control","display_name":"disease control","score":0.5299999713897705},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.3610000014305115},{"id":"https://openalex.org/keywords/hematology-consultation","display_name":"hematology consultation","score":0.36000001430511475},{"id":"https://openalex.org/keywords/united-states","display_name":"United States","score":0.3109999895095825}],"concepts":[{"id":"https://openalex.org/C2777346216","wikidata":"https://www.wikidata.org/wiki/Q1479494","display_name":"Paroxysmal nocturnal hemoglobinuria","level":2,"score":0.9861857891082764},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6070374846458435},{"id":"https://openalex.org/C2778639011","wikidata":"https://www.wikidata.org/wiki/Q1553850","display_name":"Hemoglobinuria","level":3,"score":0.5042299032211304},{"id":"https://openalex.org/C2777991916","wikidata":"https://www.wikidata.org/wiki/Q421617","display_name":"Eculizumab","level":4,"score":0.434388667345047},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2739638090133667},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2540402412414551},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.17651328444480896},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.06805205345153809},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(23)01195-3","doi":"https://doi.org/10.1016/s2152-2650(23)01195-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(23)01195-3","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4380150891","https://openalex.org/W4417012652","https://openalex.org/W4405039042","https://openalex.org/W4389259318","https://openalex.org/W4405050835","https://openalex.org/W4389234384","https://openalex.org/W4389248451","https://openalex.org/W4288085784","https://openalex.org/W4310105223","https://openalex.org/W7164340948"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-08-31T00:00:00"}